Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -16.224% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CSc1nc(Sc2ccc(Cl)cc2)c2ccccc2n1
b.) O=[N+]([O-])c1cccc(NC2=NCC(CBr)S2)c1
c.) Cc1cccn2c(=O)c(C=O)c(Sc3ncccn3)nc12
Answer: b. O=[N+]([O-])c1cccc(NC2=NCC(CBr)S2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=[N+]([O-])c1cccc(NC2=NCC(CBr)S2)c1
O=[N+]([O-])c1cccc(NC2=NCC(CBr)S2)c1
5-(bromomethyl)-N-(3-nitrophenyl)-4,5-dihydro-1,3-thiazol-2-amine